NEWSROOM

Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients

15 / 10 / 2020Press release

AMGEN, CYTOKINETICS AND SERVIER ANNOUNCE TOPLINE RESULTS FROM GALACTIC-HF, A PHASE 3 TRIAL OF OMECAMTIV MECARBIL IN PATIENTS WITH HEART FAILURE

08 / 10 / 2020Press release

The Servier Group accelerates its digital transformation and has named Virginie Dominguez as Chief Digital Officer

06 / 10 / 2020Press release

Servier and MBC BioLabs Announce Winner of the 2020 Servier Golden Ticket

24 / 09 / 2020Press release

Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors

17 / 09 / 2020Press release

Hypertension: Servier launches, with the endorsement of the International Society of Hypertension, a new edition of the public awareness campaign “Because I Say So” focused on adherence to treatment

03 / 09 / 2020Press release

Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats

18 / 08 / 2020Press release

Coalition Innovation Santé: Chronolife, with the support of Servier, Launches in France a Non-Invasive Telemonitoring Solution for the Continuous Monitoring of Patients Suffering from Chronic Diseases

23 / 07 / 2020Press release

Servier and the Autonomous University of Barcelona collaborate to accelerate research into Parkinson’s disease

30 / 06 / 2020Press release

Coalition Innovation Santé: Cureety supported by Servier and Ipsen to accelerate the deployment of its solution ensuring the continuity of care for patients with cancer

15 / 06 / 2020Press release

Servier completes the acquisition of Symphogen

04 / 06 / 2020Press release

Allogene Therapeutics, with Collaborator Servier, Reports Positive Results from its Phase 1 ALPHA Study of ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology Annual Meeting

29 / 05 / 2020Press release